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Antemortem tests for bovine tuberculosis (bTB) currently used in the US measure cell-mediated immune responses against Myco-
bacteriumbovis.PostmortemtestsforbTBrelyonobservationofgrossandhistologiclesionsofbTB,followedbybacterialisolation
ormoleculardiagnostics.CumulativedatafromthestateofMichiganindicatesthat98to99%ofcattlethatreactpositivelyinante-
mortem tests are not conﬁrmed positive for bTB at postmortem examination. Understanding the fundamental diﬀerences in gene
regulation between antemortem test-false positive cattle and cattle that have bTB may allow identiﬁcation of molecular markers
thatcanbeexploitedtobetterseparateinfectedfromnoninfectedcattle.AnimmunospeciﬁccDNAmicroarraywasusedtoidentify
altered gene expression (P ≤ 0.01) of 122 gene features between antemortem test-false positive cattle and bTB-infected cattle
following a 4-hour stimulation of whole blood with tuberculin. Further analysis using quantitative real-time PCR assays validated
altered expression of 8 genes that had diﬀerential power (adj P ≤ 0.05) to segregate cattle conﬁrmed positive for bovine tuber-
culosis from antemortem tuberculosis test-false positive cattle originating from herds free of bovine tuberculosis.
1.Introduction
Bovine tuberculosis (bTB) caused by Mycobacterium bovis
(M. bovis) occurs worldwide and has been estimated to cause
annual losses of three billion dollars to global agriculture
[1, 2]. In addition to being an important pathogen of cattle,
M.bovismayinfectmanyotherdomesticandwildlifespecies,
and it infects humans [3–5]. The zoonotic aspect of bTB
is underappreciated, as documented by The World Health
Organization recently listing bTB as a neglected zoonotic
disease [6]. Thus, control of bTB is a continuing eﬀort that
isnecessaryto protectlivestock, wildlife,and humanpopula-
tions. In many developed countries, control of bTB is based
on “test and slaughter” programs. Field and/or laboratory
diagnostic tests are used to identify potentially infected cattle
herds for quarantine, which may be followed by additional
diagnostic testing and slaughter of all cattle that show posi-
tive test reactions. Although proven eﬀective, “test and
slaughter” programs are costly and have not been adopted
by most developing countries.
The bTB control program in the United States (US) has
reduced the prevalence of bTB-infected cattle herds from an
estimated 5% of all herds in 1917 to an estimated infec-
tion rate of <0.001% for all herds [7]. Most antemortem
diagnostic tests currently approved in many countries for
detection of bTB measure cell-mediated immune responses.
In the US, approved tests include the caudal fold tuberculin
skin test (CFT), as the primary screening test, and either the
comparative cervical tuberculin skin test (CCT) or the whole
blood interferon-gamma (IFN-γ) ELISA assay as secondary2 Veterinary Medicine International
tests. Cattle that show positive reactions in successive pri-
mary and secondary tests usually are culled for postmortem
examination. Predictably, as prevalence of bTB-infected
cattle decreases, the proportion of antemortem test-false
positive cattle culled for postmortem examination increases
[8]. The prevalence of bTB in the state of Michigan is low,
and only 1-2% of cattle that show positive responses on two
successive antemortem tests are conﬁrmed as positive for
bTB at postmortem examination [9]. Thus, there is a need
forancillaryantemortemtestsforbTBthatimprovetheposi-
tive predictive value of the testing process.
DNA microarray technologies facilitate rapid and large-
scale examination of global gene expression proﬁles. This
allows eﬃcient detection of target genes that might be
aﬀected by a treatment or a disease process. This approach
for identiﬁcation of altered gene expression is particularly
useful in studies of host response to various infections [10–
13].Alteredgeneexpressionproﬁlesmayshowcommonpat-
ternsofresponseacrossdiﬀerenthostcelltypeswithdiﬀerent
pathogens [10, 11]. Also, unique gene expression signatures
can be identiﬁed in a host’s response to a speciﬁc pathogen.
This may be attributed to pathogen-driven diﬀerences in
reprogramming of host gene transcription at the host-
pathogen interface [12–14]. Thus, mining diﬀerential host
transcriptome response to identify molecular events associ-
ated with pathogenesis oﬀers an opportunity for discovery
of diagnostic molecular markers predictive for speciﬁc
infectious, metabolic, or genetic diseases [15–18]. Recently,
microarray platforms of bovine genes have been used to
study pathogenic processes and to identify molecular mark-
ers of infection, for two mycobacterial pathogens of cattle;
M. avium subspecies paratuberculosis (MAP) and M. bovis
[15, 16, 19–24].
Peripheral blood transcriptome proﬁles are particularly
useful for identiﬁcation of pathogen-associated immune
response signatures, which can be used to develop diagnostic
tools [10, 12, 14, 23]. Previous studies of bTB by Meade et al.
[16, 21, 22] compared peripheral blood mononuclear cells
(PBMCs) of cattle that had bTB with normal healthy cattle
that tested negative for bTB. In the current study, we com-
pared diﬀerential gene expression in cattle that had bTB
with cattle that were single or double antemortem test-false
positive for bTB. The intent was to identify diﬀerential gene
expression proﬁles among cattle that have similar reactions
in antemortem bTB tests but diﬀer in their infection status
at postmortem examination. Using this approach is critical
because cattle that are antemortem test-false positive for bTB
currently are not diﬀerentiated from truly infected cattle
until a time-consuming and expensive postmortem diag-
nostic process is completed. Our overall objective was to
identify gene targets that can be used for diﬀerentiation of
antemortem test-false positive cattle from cattle that have
bTB.
2.MaterialsandMethods
2.1. Experimental Animals and bTB Infection Status. Cattle
used in this study were submitted for postmortem examina-
tion because of positive reactions in antemortem diagnostic
testsforbTB.CattleweretransportedtotheDiagnosticCen-
ter for Population and Animal Health (DCPAH) at Michigan
State University (MSU) the day before humane euthanasia
and postmortem examination were performed. A presump-
tive positive or negative diagnosis was made at the DCPAH
based on the presence of gross and/or microscopic lesions.
Regardless of the presumptive diagnosis, samples from all
cattleexaminedweresubmittedtoUnitedStatesDepartment
of Agriculture’s National Veterinary Services Laboratories
(NVSLs). Final diagnosis was made by the NVSL based on
results of polymerase chain reaction (PCR) assays and/or
mycobacterial culture.
Three study groups of cattle were used for microarray
analysis.ThestudygroupsincludedbTBpositivecattle(bTB,
n = 4),whichwerepositiveforlesionsofbTBatpostmortem
examination and conﬁrmed positive by the NVSL; double
antemortem test-false positive cattle (DFP, n = 4), which
showed positive reactions on primary and secondary diag-
nostic tests for bTB but were negative for lesions of bTB at
postmortem examination, and were conﬁrmed negative for
bTB by the NVSL; and single antemortem test-false positive
cattle (SFP, n = 7), which were positive on the CFT but were
negative on the CCT or IFN-γ assay, were found negative for
lesions of bTB at postmortem examination and were con-
ﬁrmed negative for bTB by the NVSL. The number of cattle
in each group was expanded to 10 for validation of altered
gene expression, using quantitative real-time PCR (qPCR)
assays. Finally, healthy cattle from long-term bTB negative
farms (n = 12) with recent negative test records for bTB,
MAP, bovine leukosis virus, and bovine viral diarrhea virus
were used as blood donors to obtain a reference pool of
control RNA for the study.
2.2. Blood Collection, Antigen Stimulation, and RNA Extrac-
tion. Blood (∼45mL) was collected from each animal in the
bTB, DFP, and SFP groups into 10mL heparin-containing
evacuated tubes (Vacutainer, BD Diagnostics, Franklin
Lakes, NJ) immediately before euthanasia for postmortem
examination. Within 3 hours of collection, the blood from
each animal was pooled into individual sterile 50mL conical
tubes and stimulated with puriﬁed protein derivative pre-
pared from heat-killed cultures of M. bovis (bPPD) (Prionics
AG, Switzerland) at 20μg bPPD/mL of blood. The blood
was incubated at 38 ± 1◦C for 4-hours prior to harvest.
Blood samples from the 12 healthy cattle were similarly col-
lected, processed, and stimulated. The 4 hour period for
antigen stimulation was chosen because it was considered
the maximal time that could be used if receipt of sample,
stimulation of blood, and extraction of RNA were to occur
during a 10-hour diagnostic laboratory work day.
After stimulation, the blood was centrifuged at 1200×g
for 15 minutes at 18◦C to form layers of plasma, buﬀyc o a t
cells and red blood cells. The buﬀy coat layer of cells, and
2mL of red blood cells immediately below the buﬀyc o a t
layer were harvested by aspiration and transferred to a new
50mL conical tube. Two rounds of hypotonic lysis of red
blood cells were performed by addition of ice-cold diethyl-
pyrocarbonate (DEPC) treated-sterile deionized water for 2
minutes, followed by addition of an equal volume of ice-coldVeterinary Medicine International 3
DEPC-treated sterile 2X saline (1.7% w/v NaCl). Intact cells
were pelleted by centrifugation at 1200×gf o r1 5m i n u t e sa t
18◦C after the ﬁrst round of hypotonic lysis, then at 190×g
for 10 minutes at 4◦C after the second round. After the sec-
ond round of hypotonic lysis, the supernatant was decanted,
and 1mL TRIzol Reagent (Invitrogen, Carlsbad, CA) was
addedtotheloosecellpelletforeach9mLbeginning volume
of whole blood. This mixture was frozen at −84◦C until use.
For isolation of RNA, the mixture was thawed on ice and
subjected to 10 passages through a 20-gauge needle. The
resulting homogenate was divided into 1mL aliquots, and
the remainder of the RNA extraction procedure was per-
formed according to the manufacturer’s recommendations.
The total cellular RNA from each animal was then pooled
into a single tube and treated with RQ1 RNase-Free DNase
(Promega, Madison, WI) according to manufacturer’s rec-
ommendations. The treated RNA was extracted again using
equal volumes of phenol-chloroform, followed by puriﬁ-
cation using MEGAclear Puriﬁcation Kit (Ambion, Austin,
TX). The puriﬁed RNA was immediately stored at −84◦C
until use.
Before use, the RNA from the study cattle was thawed
on ice, and the integrity and concentration of the RNA was
determined using the Agilent 2100 Bioanalyzer and RNA
Nano 6000 Kit (Agilent Technologies, Santa Clara, CA). The
RNA from the 12 healthy cattle was mixed to form a homo-
genous control reference pool and the integrity and concen-
tration of that pooled RNA was similarly determined.
2.3. Experimental Design, cDNA Synthesis, and Microarray
Hybridization. The BOTL-5 cDNA microarray used in this
study was the 5th generation of a previously described
bovine total leukocyte immunospeciﬁc microarray [25, 26].
The gene content and sequence information for BOTL-5
microarray are available at the National Center for Biotech-
nology Information Gene Expression Omnibus (NCBI GEO,
platform number GPL5751). Brieﬂy, BOTL-5 contains 3,888
featuresincluding1,391bovineexpressedsequencetag(EST)
cloned inserts and PCR amplicons derived from known
sequencesofbovineimmuneresponsegenes,spottedindup-
licate along with multiple replicates of microarray speciﬁc
control features. A common reference design was used for
microarray hybridization in this study. That design was
selected because the cattle used were submitted for post-
mortem examination over a two-year period. The use of a
common reference on each microarray allowed comparison
of gene expression of individual samples obtained over a
large time span, and allowed comparison of gene expression
across the various study groups [27–29].
The cDNA synthesis and dye labeling were performed
with 15μg aliquots of total RNA using the SuperScript III
Fluorescent Labeling Kit containing Cy5 and Cy3 dyes (Cat
no. L101401; Invitrogen Corp., Carlsbad, CA) following the
manufacturer’s recommendations. RNA from the study
cattle was labeled with the Cy3 dye and cohybridized with
the control reference pool of RNA labeled with Cy5 dye.
Foreachmicroarrayexperiment,theCy3-labeledsampleand
Cy5-labeledreferencepoolwerecombinedandconcentrated,
using a Microcon 30 centrifugal ﬁlter unit (Millipore, Biller-
ica, MA). The labeled cDNA mixture was eluted in 110μL
ofSlideHybbuﬀerno.3(Ambion,Austin,TX)andheatedfor
5m i n u t e sa t7 0 ◦C prior to hybridization. The hybridization
was done using a GeneTAC HybStation (Genomic Solutions
Inc., Ann Arbor, MI) and an 18-hour step-down protocol (3
h o u r sa t6 0 ◦C, 3 hours at 55◦C ,1 2h o u r sa t5 0 ◦C). Imme-
diately following hybridizations, the slides were subjected
t o5w a s h e so f3 0s e c o n d se a c ha t5 0 ◦C with 2x SSC con-
taining 0.1% SDS, 5 washes of 30 seconds each at 42◦Cw i t h
0.2x SSC containing 0.1% SDS and 5 washes of 30 seconds
each at 42◦C with 0.2x SSC. After removal from the hybrid-
izationunit,themicroarrayslideswererinsedoncein2xSSC
and once in double-distilled water and then dried by cen-
trifugation for two minutes at 1,200×g. Hybridized cDNA
microarrays were scanned immediately using a GeneTAC LS
IV microarray scanner and GeneTAC LS software (Genomic
Solutions Inc., Ann Arbor, MI).
2.4. Data Processing, Normalization, and Analysis. Microar-
ray images were processed using GenePix Pro 6.0 software
(Molecular Devices, Downingtown, PA) to generate spot
intensity ﬁles. The output ﬁles were analyzed using the
LIMMA (LInear Models for MicroArray) software package
[30] implemented in the R language and environment
(http://www.r-project.org/)[31].Brieﬂy,backgroundcorrec-
tion [32] and within microarray normalization [33]w e r e
performed prior to linear regression analysis. Prior to and
after normalization, MA plots of data were generated for
visual assessment of the normalization eﬀect. Log-ratios of
median ﬂuorescence intensities were used for data analysis.
The empirical Bayes moderated T statistic [34]w a su s e dt o
verify altered expression of gene features within each group
of cattle (SFP, DFP, and bTB) and between groups of cattle
(bTB versus SFP, bTB versus DFP, and DFP versus SFP).
2.5. Quantitative Real-Time PCR (qPCR) Validation of Dif-
ferential Gene Expression. Twelve potential reference genes
were evaluated for stability of expression level within and
between the study groups of cattle, using 3 available pro-
grams(BestKeeper,NormFinder,andgeNorm)[35].Succinate
dehydrogenase complex subunit A (SDHA) was determined
to be the most suitable reference gene for this study (data
not shown). The list of 33 genes selected for validation of
expression using qPCR assay, PCR primer sequences, primer
concentration, PCR eﬃciency, and amplicon size are given in
Table 1. The PCR primers for the gene targets were designed
using Clone Manager Suite 7.0 (Sci-Ed Software, Cary, NC)
or Primer Express 3.0 software (Applied Biosystem, Foster
City,CA)andweresynthesizedbyIntegratedDNATechnolo-
gies(Coralville,IA).Allprimersweretestedforampliﬁcation
with the control reference pool of RNA and with a no
template control (NTC). Optimal primer concentration for
qPCR was empirically determined (data not shown).
Validation of altered gene expression using qPCR was
done for 17 gene features selected from the microarray data.
Those gene features showed substantial altered expression
among cattle or showed unique regulation within a group of4 Veterinary Medicine International
Table 1: Genes selected for qPCR analysis, the nucleic acid sequence and concentration (nM) of PCR primers for those genes (forward
primer (F) and reverse primer (R)), the PCR eﬃciency (E), and the PCR amplicon sizes (bp).
Gene symbol Gene name Primer (5 -3 ) Primer conc.
(nM)
PCR eﬀ.
(E)
Amplicon
size (bp)
# ARF3 ADP-ribosylation factor 3 F: TTGCCTAATGCCATGAATGC
R: CACAGGTGGCCTGAATGTA 300 1.817 91
#B O L A - D M AMajor histocompatibility
complex, class II, DM α-chain
F: TTGTTGGCTTGGTCCTCTTC
R: ACACCTCCTGCTTGGATGG 300 1.975 105
# BOTL08 C07 Unknown F: ATCACTTCCCGCCTCCTTAG
R: AGGCAGGTGACCAAGGAAAC 600 1.925 92
# CXCL2 C-X-C ligand 2 (GRO-alpha) F: AACAAGGCTAGTGCCAACTG
R: CCACTGAGGCTGCTGGAG 300 1.912 68
# DDX5 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 5
F: AGAGATCTGGTGGGTAGCTTTA
R: ACCCTATCCTCTCCTTGCAAAC 300 1.917 79
# IL-4 interleukin-4 F: GCCACACGTGCTTGAACAAA
R: TGCTTGCCAAGCTGTTGAGA 450 1.910 63
#L T B RLymphotoxin beta receptor
(TNFR superfamily member3)
F: CCGGAGTGACGAGGAAGAC
R: CAAAACTCGCCCTTATACCTTG 450 1.859 104
# PPP2R5B
Protein phosphatase 2,
regulatory subunit B
 ,b e t a
isoform
F: GTGGTCCTGGCAACAGAAC
R: CTGGAGCCCAGCTTTGTG 300 1.895 110
# PRKCI Protein kinase C, iota F: CAAGGACCCAAAGGAACGATT
R: ACCACCTGCTTTTGCTCCAT 300 1.897 114
#P T G S 2Prostaglandin-endoperoxide
synthase 2(cyclooxygenase-2)
F: CGACACCAAGAACGTATTCCTA
R: GAGATGTGGAAAAGAAGCATTG 300 1.930 105
∗ BOLA-DRA MHC class II DR alpha F: GCTCTGGTGGGCATCATTG
R: CCTCGGCGTTCAACGGTG 300 1.910 77
∗ TPRA1 Transmembrane protein,
adipocyte associated 1
F: GTGCGCAGACATCATTGAG
R: GGCGCAAAGAAGCTGAAG 450 1.974 72
∗ TRIM13 Tripartite motif-containing 13 F: CTGGCACGTTCATTAGCAAG
R: GGCCAAGCAGAATGACCAC 300 1.962 69
∗ FCGRT Fc fragment of IgG, receptor,
transporter, alpha
F: GGCCCGAATCGTTGTGTT
R: GAAGCCCAAGGCTTACACC 450 1.822 81
∗ TMX4 Thioredoxin-related
transmembrane protein 4
F: ACCTTGACTTGTGCTCACTT
R: TGGAGGTACCACTGGAACTG 300 1.993 85
∗ BOTL11 A05 Unknown F: CACACTCTATGGCGCAAATC
R: CCCTGGACCACCACCTCTA 300 1.903 75
∗ RPL19 Ribosomal protein L19 F: GGCTCCAGGCCAAGAAAG
R: AATTGCCGAGGCCACTATG 300 1.972 106
§ CSF3 Colony stimulating factor 3
(granulocyte)
F: CTGGGTGAGACTGGGAAATG
R: TCTCTCACACCCCGTCACA 300 1.959 62
§ GCP2 Granulocyte chemotactic protein
2 (CXCL6)
F: CATTGGAATGCTGTATATGGAGAT
R: TCTTCCAAAGGTCAAGAGTAAGA 300 1.874 122
§ IL-10 Interleukin-10 F: CTTGTCGGAAATGATCCAGTTTT
R: TCAGGC CCGTGG TTCTCA 300 1.948 66
§ IL-10RA Interleukin-10 receptor A F: GTCACCCTGCCACTGATCAC
R: GGCAGCGTGCAGCTGAAATC 300 1.828 84
§ IL-6 Interleukin-6 F: GGCTCCCATGATTGTGGTAGTT
R: GCCCAGTGGACAGGTTTCTG 300 1.873 64
§ IL-12p40 Interleukin-12, p40 subunit F: CAAACCAGACCCACCCAAGA
R: GACCTCCACCTGCCGAGAA 300 1.896 64
§ IL-15 Interleukin-15 F: GGCTGGCATTCATGTCTTCA
R: CATACT GCCAGT TTGCTTCTGTTT 300 1.850 74Veterinary Medicine International 5
Table 1: Continued.
Gene symbol Gene name Primer (5 -3 ) Primer conc.
(nM)
PCR eﬀ.
(E)
Amplicon
size (bp)
§ IL-18 Interleukin-18 F: GAAAATGATGAAGACCTGGAATCA
R: ACTTGGTCATTCAAATTTCGTATGA 300 1.896 84
§ IL-1b Interleukin-1 beta F: AAGCAGGCGCATCTGTGAA
R: ATGGCACTCTAACCCGGAAA 450 1.915 70
§ IL1R2 Interleukin-1 receptor 2 F: ATACCTGTGCCATGACGTATGC
R: CGGAGTTTGATATTCCTGGTGAT 300 1.923 67
§ IL2 Interleukin-2 F: TGATGCAACAGTAAACGCTGTAG
R: GAGAGGCACTTAGTGATCAAGTC 450 1.928 95
§ IL-1α Interleukin-1 alpha F: TTGGTGCACATGGCAAGTG
R: GCACAGTCAAGGCTATTTTTCCA 450 1.948 72
§ IL-8 Interleukin-8 F: GGAAAAGTGGGTGCAGAAGGT
R: GGTGGTTTTTTCTTTTTCATGGA 100 1.888 80
§ INF-γ Interferon, gamma F: TGGCATGTCAGACAGCACTTG
R: CCTGAAGCGCCAGGTATAAGG 450 1.932 96
§ TGFβ Transforming growth
factor, beta
F: CTGAGCCAGAGGCGGACTAC
R: TGCCGTATTCCACCATTAGCA 300 1.897 63
§ TNFα T u m o rn e c r o s i sf a c t o r ,
alpha
F: TCTACCAGGGAGGAGTCTTCCA
R: GTCCGGCAGGTTGATCTCA 300 1.871 68
SDHA Succinate dehydrogenase
complex subunit A
F: CCACGCCAGGGAGGACTTC
R: CGTAGGAGAGCGTGTGCTTC 300 1.879 116
#Genes that showed substantial altered expression within a group of cattle in microarray studies.
∗Genes that had diﬀerential power between groups of cattle using microarray expression data analyzed with MAANOVA.
§Genes that were selected from the literature as being relevant to the bTB infection.
cattle (Table 1). An additional 16 genes coding for cytokines
or chemokines were selected from the literature for qPCR
analysis (Table 1). The cytokines or chemokines produced by
those genes are reported as important mediators in bovine
andhumanTBinfections.SamplesofRNAfrom30cattle(10
cattle per study group) were used to assess altered expression
of the 33 selected genes. The samples of RNA subjected for
qPCR included some of the original samples used in the
microarray experiments plus new samples of RNA from
additional cattle that met the criteria for each study group.
Synthesis of cDNA was performed with 2μgo ft o t a lR N A
from each study animal and from the common reference
pool of RNA, using commercially available reagents (Super-
script II Reverse Transcriptase and Oligo (dT)12–18 Primer,
Invitrogen, Carlsbad, CA) and the manufacturer’s recom-
mended protocol. Upon completion of cDNA synthesis, the
RNA template in each reaction was removed with 1U of
RNaseH(Invitrogen,Carlsbad,CA).ThecDNAwaspuriﬁed
using QuickClean enzyme Removal Resin (Clontech Labo-
ratories, Mountain View, CA). Finally, the concentration of
puriﬁed cDNA was measured by spectrometry (ND-1000,
NanoDrop Technologies, Wilmington, DE) and diluted to
ﬁnal concentration of 10ng/μL. The cDNA was stored at
−20◦C until use in qPCR assays.
The qPCR assays were performed in triplicate using
SYBR Green PCR Master Mix and an ABI 7500 Real-time
PCR System (Applied Biosystems, Foster City, CA). Each
20μL reaction consisted of 1x SYBR Green PCR master mix,
30ng of cDNA, and a pair of primers at predetermined opti-
mal concentrations (Table 1). The reaction conditions were
95◦C for 10 minutes, then 40 cycles of 95◦C for 15 seconds,
and 58◦C for 1 minute. Dissociation curve analysis was done
for each reaction.
2.6. PCR Eﬃciency Determination and qPCR Data Analysis.
The magnitude of the normalized reporter signal (delta Rn)
data and the cycle threshold (Ct) data exported from the ABI
7500 SDS software were used to verify that acceptable PCR
eﬃciency (>1.8) was achieved and to calculate the relative
expression level of the targeted genes, respectively. The ef-
ﬁciency of each qPCR reaction was determined based on the
slope of the exponential phase of the reaction, using the Lin-
RegPCR program [36]. The mathematical model for calcu-
lation of relative gene expression proposed by Pfaﬄ et al. was
used for qPCR analysis [37]. The SDHA gene was used as the
reference/normalizer gene, and the common reference pool
(asinthemicroarrayexperiments)wasusedasthecalibrator.
For each animal, the mean Ct value from triplicate reactions
for each gene target was used to determine the relative gene
expression value. To calculate the mean diﬀerential expres-
sion of a gene target for an entire study group, the relative
gene expression values of the gene target for each animal
within the group were averaged. Thus, the calculated mean
diﬀerential expression represents altered expression of a gene
target among cattle in a study group relative to the common
referencepoolofRNA.TheStudent’st-testwasusedtodeter-
mine the statistical signiﬁcance of altered expression of gene
targets within each study group (SFP, DFP, and bTB).
The relative gene expression values of each gene target
for each animal in a group were used to determine the sig-
niﬁcance of diﬀerential expression of a gene target among
groups of cattle (bTB versus SFP, bTB versus DFP, and DFP6 Veterinary Medicine International
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Figure 1: Number of genes from microarray analysis that were dif-
ferentially expressed (P ≤ 0.01) within single antemortem test-false
positive (SFP), double antemortem test-false positive (DFP), and
bTB-infected (bTB) groups of cattle. The RNA used for microarray
analysis was harvested after a 4-hour stimulation of whole blood
with tuberculin, and comparison of gene expression levels was with
areferencepoolofmRNAharvestedfromthebloodofhealthycattle
after 4-hour stimulation with tuberculin. The number of genes for
each group of cattle that showed increased expression (solid box) or
decreased expression (shaded box) relative to the reference pool of
RNA is indicated by the ﬁgure in the boxes.
versus SFP). The analysis was performed with the ANOVA
test based on linear ﬁxed eﬀect models [38], implemented in
the MAANOVA software package [39]. Simultaneous ﬁtting
of multiple linear models was done with 5000 permutation
tests and with the jsFDR method for false discovery rate
(FDR) adjustment [40].
3. Results
3.1. Identiﬁcation of Altered Gene Expression Proﬁles from
Microarray Data. A total of 1,391 gene features on the
BOTL-5 microarray were analyzed, of which, 122 gene fea-
t u r e sw e r ed i ﬀerentially expressed (P ≤ 0.01) in one or more
groups of cattle. Only 9 of the 122 gene features were shared
by two groups of cattle; the remaining 113 genes were uni-
quely regulated within individual groups of cattle (SFP, DFP,
and bTB). Overall, we found more genes with altered expres-
sion in each group of antemortem test-false positive cattle
than in the bTB positive cattle. In both the SFP and DFP
groups of cattle, the ratio of gene features showing increased
expression levels to those showing decreased expression
levels was at least 2:1. In contrast, the ratio of increased
expression to decreased expression was 1:1 in the bTB
group of cattle (Figure 1). The complete list of diﬀerentially
expressed gene is provided in Supplementary Table S1 (see
Table S1 in Supplementary Material available online at doi:
10.1155/2012/192926).
The objective of this study was to ﬁnd molecular markers
that can diﬀerentiate antemortem test-false positive cattle
frombTBinfectedcattle.Whenacomparisonofgeneexpres-
sion data was done between groups of cattle, only 55 gene
11
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Figure 2: Numbers of gene features identiﬁed from analysis of
microarraydatathatwerediﬀerentiallyexpressed(P ≤ 0.01)among
single antemortem test-false positive (SFP), double antemortem
test-false positive (DFP), and bTB-infected (bTB) groups of cattle.
Thenumbersofgenes commontooruniqueforthegroupsofcattle
are shown in a Venn diagram.
features showed signiﬁcant statistical power to diﬀerentiate
the study groups from each other (bTB versus SFP, bTB
versus DFP, and DFP versus SFP). The complete list of those
genes is provided in Supplementary Table S2. Using the data
generated from analysis of the microarrays, diﬀerentiation
of a particular group of cattle from each of the other two
g r o u p sw a sp o s s i b l e ,b u to n l yaf e wg e n ef e a t u r e sw e r eu s e f u l
for that purpose (Figure 2). The DFP group of cattle could
be diﬀerentiated from the bTB and the SFP groups using
the altered expression levels of 5 gene features. Those genes
were thioredoxin-related transmembrane protein 4 (TMX4);
transmembrane protein, adipocyte associated 1 (TPRA1);
major histocompatibility complex, class II, DM alpha-chain
(BOLA-DMA); Fc fragment of IgG, receptor transporter
alpha (FCGRT); ribosomal protein L19 (RPL19). The altered
expression level of only one gene feature, tripartite motif-
containing 13 (TRIM13), was useful for diﬀerentiating
the SFP group of cattle from the bTB and DFP groups.
Similarly, altered expression of only one gene feature, clone
BOTL0100011 A05 (a gene feature of unknown function),
was useful for diﬀerentiation of the bTB group of cattle from
the SFP and DFP groups.
3.2. Group Level Gene Expression Proﬁling with Quantitative
Real-Time PCR (qPCR) Data. With the extended panel of 10
cattle per study group, the statistical signiﬁcance of the
mean altered gene expression within each group of cattle
could be assessed with greater accuracy. The qPCR assays
identiﬁed many genes that showed considerable variation in
expression level among cattle within all study groups. Seven
genes showed increased expression in all 3 study groups, and
12 genes showed decreased expression in all 3 study groups
(Figures 3(a) and 3(b)). The gamma interferon (IFN-γ)g e n e
showed the greatest increase in expression in all study groupsVeterinary Medicine International 7
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Figure 3: The relative gene expression levels compared with the reference pool of RNA from healthy cattle, as determined by qPCR assays,
for the single antemortem test-false positive (SFP, shaded box), double antemortem test-false positive (DFP, solid box), and bTB-infected
(bTB, clear box) groups of cattle. Gene expression levels (in log2 fold change) were calculated using the published mathematical algorithm
[37] in which the reference pool of RNA was set as baseline (0 value at Y-axis) and used as the calibrator. Statistically signiﬁcant diﬀerences
were determined using Student’s t-test and are shown at P ≤ 0.05 (∗)a n dP ≤ 0.01 (∗∗). The error bars represent the standard error of the
mean expression level for a group of cattle. (a) Genes with increased expression in all groups of cattle. (b) Genes with decreased expression
in all groups of cattle.
(2.92- to 7.42-fold). Interleukin-2 (IL-2) also showed a
marked increase in expression (1.84- to 2.74-fold). Other
genes that showed increased expression in all groups of cattle
were serine/threonine-protein phosphatase 2A 56kDa regu-
latory subunit beta isoform (PPP2R5B), lymphotoxin beta
receptor (LTBR), ADP-ribosylation factor 3 (ARF3), and
2 clones with unknown function (BOTL0100008 C07 and
BOTL0100011 A05).
Proinﬂammatory cytokines were among the downregu-
lated genes, including interleukin-6 (IL-6), tumor necrosis
factor alpha (TNF-α), and interleukin-1 alpha (IL-1α). Also
downregulated were anti-inﬂammatory cytokines, includ-
ing interleukin-10 (IL-10) and transforming growth factor
beta (TGF-β), along with several chemokines, including
interleukin-8 (IL-8), chemokine (C-X-C motif) ligand 2
(CXCL-2), and chemokine (C-X-C motif) ligand 6 (GCP2).
Decreased expression of many of those genes was especially
evident in cattle from the DFP group. Other genes that
showed decreased expression included the major histo-
compatibility complex Class II molecule (BOLA-DMA),
prostaglandin-endoperoxide synthase 2 (PTGS2), tripartite
motif-containing 13 (TRIM13) and transmembrane protein,
adipocyte associated 1 (TPRA1).
3.3. Analysis of Altered Gene Expression in Individual Cattle.
The data from qPCR assays were analyzed at the individual
animal level using the ANOVA test to identify genes that
could signiﬁcantly diﬀerentiate individual cattle within a
group from cattle in the other groups. Of the 33 genes
selected for qPCR assay, 17 were found to have diﬀerential
power at adj P ≤ 0.05. The expression levels of 16 of those
genes could be used to diﬀerentiate DFP cattle from SFP
cattle (Figure 4(a)). Only 5 genes diﬀerentiated bTB cattle
from DFP cattle, and only 1 gene signiﬁcantly diﬀerentiated
bTB cattle from SFP cattle. These results suggest that the
gene expression proﬁle of the SFP cattle was more similar to
that of the bTB cattle than the DFP cattle. This ﬁnding was
unexpected, because it was anticipated that the SFP and the
DFP groups of cattle would be closer in expression proﬁle to
each other than to the bTB cattle.
All10SFPcattleand4of10cattleintheDFPgrouporigi-
nated from bTB-positive herds and may have been exposed
withM. bovis. Exposure with M. bovis might have inﬂuenced
the gene expression proﬁles. The remaining 6 cattle in DFP
group that did not have a history of bTB exposure were des-
ignated as double antemortem test-false positive non-bTB
exposed (DFP-non-ex, n = 6), and the gene expression data8 Veterinary Medicine International
PRKCI
CXCL2
PTGS2
FCGRT
IL-6
IL10RA
IL1R2
IL-1α
TGF-β
IL-8
IL-18
TMX4
TNFα
IL-15
CSF3
bTB versus DFP
DFP versus SFP bTB versus SFP
IL-12-p40
IL-10
(a)
FCGRT
IL-6
IL10RA
IL1R2
IL-1α
IL-1β
IL-10
IL12-p40
TNFα
IL-15
CXCL2
PTGS2
CSF3
BOLA-DRA
ARF3
PRKCI
bTB versus DFP-no-ex
DFP-no-ex versus SFP bTB versus SFP
(b)
Figure 4: Venn diagrams showing the statistically signiﬁcant (adj P ≤ 0.05) diﬀerentially expressed genes that were unique to or common
among(a)singleantemortemtest-falsepositive(SFP),doubleantemortemtest-falsepositive(DFP),andbTB-infected(bTB)groupsofcattle
in initial analysis of 30 cattle and (b) single antemortem test-false positive (SFP), double antemortem test-false positive non-bTB-exposed
(DFP-non-ex), and bTB-infected (bTB) groups of cattle after removal of bTB-exposed cattle from the DFP group. The gene expression levels
were determined by qPCR assay, where each animal was calibrated relative to the reference pool of RNA from healthy cattle; diﬀerential
expression between 2 groups of cattle (i.e., X versus Y) was determined using ANOVA analysis.
from the qPCR assays were reanalyzed for this new group.
Overall, removal of bTB-exposed cattle from the DFP-non-
ex group did not have a statistically signiﬁcant (adj P ≤ 0.05)
eﬀect on the mean expression values for most of the genes
previously identiﬁed. However, the mean expression levels
of 8 down regulated genes in the DFP-non-ex group were
further down regulated by >2-fold change. Those genes
are CXCL2, GCP2, IL-10, IL-1α, IL-1R2, IL-6, IL-8, and
PTGS2. In addition, the mean expression levels of IFN-γ
and PPP2R5B were no longer statistically signiﬁcant for the
DFP-non-ex group. The loss of statistical signiﬁcance was
attributed to the wide range of expression levels for those
genes among the cattle and the reduction in the size of the
group from 10 to 6 cattle.
Removal of the bTB-exposed cattle from the DFP group
also aﬀected the analysis at the individual animal level, using
the ANOVA test. The diﬀerential power of 4 genes (TGF-β,
IL-8, IL-18, and TMX4) was no longer statistically signif-
icant, but 2 additional genes (BOLA-DRA and ARF3) had
statistically signiﬁcant diﬀerential power among 2 or more
groups of cattle. Thus, altered expression level of 15 genes
was deemed signiﬁcant (adj P ≤ 0.05) for diﬀerentiation
of the 3 groups of cattle (Figure 4(b)). After removal of the
bTB-exposed cattle, the number of genes that could be used
to diﬀerentiate cattle in the DFP-non-ex group from cattle in
t h eb T Bg r o u pi n c r e a s e df r o m5t o8( Table 2).
4. Discussion
Currently, the OIE-approved bTB tests for international
trade of cattle are the tuberculin skin tests (TSTs), which are
based on a physically measurable cell-mediated inﬂamma-
tory response against tuberculin antigen injected into either
the skin of the neck or the caudal fold of the tail, and the
Table 2: Genes that showed diﬀerential power (adj P ≤ 0.05)
between cattle that were double antemortem test-false positive with
no bTB-exposure history (DFP-non-ex) and cattle that were bTB
infected (bTB), as determined by qPCR analysis. The diﬀerential
expression level (Δlog2 FC) of the bTB and DFP-non-ex groups
of cattle (bTB minus DFP-non-ex) was determined using ANOVA
analysis.
Gene Δlog2 FC (bTB versus DFP-non-ex) adj P
IL-10 1.852 0.0314
IL12-p40 1.975 0.0267
TNFα 1.809 0.0217
PTGS2 3.413 0.0183
CSF3 2.199 0.0175
CXCL2 2.498 0.0175
BOLA-DRA 1.010 0.0175
ARF3 0.736 0.0175
IFN-γ ELISA assay, which measures IFN-γ secreted into
plasma after stimulation of whole blood with tuberculin
antigen [2, 41]. The TSTs are most commonly used to
screen for bTB and normally are eﬀective for control of bTB.
However, limitations in sensitivity and speciﬁcity of TST
havelongbeenrecognized[2,42].Toincreasediagnosticsen-
sitivity, the IFN-γ ELISA assay is used in some countries in
parallel with, or sequential to, various applications of the
TST [43, 44]. Regardless of testing schemes employed, false
positiveandfalsenegativetestresultsremainanissueforbTB
control programs. In Michigan, the current rate of bTB-
infection is extremely low, which leads to far more ante-
mortem test-false positive cattle being culled as bTB sus-
pects than the number of bTB infected cattle identiﬁed atVeterinary Medicine International 9
postmortem examination. This has driven our interest in
comparing the gene expression proﬁles of bTB-positive and
bTB antemortem test-false positive cattle. We hypothesized
that altered transcription levels of select genes could dis-
criminate between cattle infected with bTB and cattle that
wereantemortemtest-falsepositiveusingcurrentlyapproved
diagnostic assays.
To test our hypothesis, mRNA expression levels were
evaluated by microarray analysis that made use of a common
reference design. The common reference used in the current
study was a pool of RNA extracted from PBMC of healthy
cattle after samples of whole blood from those cattle were
stimulated for 4 hours with bPPD. The methods for antigen-
stimulation and for RNA extraction from PBMC of healthy
cattle were identical to those used for the 3 study groups
of SFP, DFP, and bTB cattle. Previous studies have shown
that bPPD stimulation of PBMC from healthy cattle will
induce altered gene expression [16, 22]. By normalizing each
microarray with a pool of RNA from antigen stimulated cells
obtained from healthy cattle, it was hoped that any changes
in gene expression that were due to nonspeciﬁc stimulation
caused by bPPD would be ﬁltered out.
After 2–4 hours of antigen stimulation, comparable
microarray studies on cattle infected with MAP [45]o rb T B
[16,22]haveshownrapidchangesingeneexpressionproﬁles
of PBMC. Importantly, a marked increase was reported in
the number of diﬀerentially expressed genes in bTB-positive
cattle compared with TST-negative cattle following a 3-hour
stimulation of whole blood with bPPD [16]. In the current
study, we also found rapid changes in gene expression in
bTB-positive cattle (bTB group) and in antemortem test-
false positive cattle (SFP and DFP groups), after stimulation
of blood with bPPD for 4 hours. At 0.01 level of signiﬁcance,
the number of genes showing altered expression was similar
among the SFP (n = 51) and DFP groups (n = 60). In com-
parison, the numbers of genes showing altered expression in
the bTB group were substantially less (n = 20). Most genes
that showed altered expression were unique to the individual
groups of cattle, and only a few genes were shared among 2
or more groups of cattle.
Although microarray hybridization analyses are useful
as a general screening tool for identifying genes that show
altered expression [13, 23], qPCR is accepted as the more
sensitive and accurate assay for quantifying diﬀerential gene
expression [46, 47]. Thus, qPCR was used to validate altered
expressionlevelsforselectgenes.TheqPCRassaysconducted
in the current study conﬁrmed that there were diﬀerences in
gene expression between the SFP, DFP, and bTB groups of
cattle (Figure 3). Compared with the reference pool of RNA,
the expression of many genes was decreased at 4 hours after
stimulation, especially in the DFP group of cattle. This
ﬁnding was consistent with other studies that report a tem-
poral decrease in level of gene expression following antigen
stimulation of PBMC [22, 45]. The greatest increase in gene
expression was observed for the cytokine IFN-γ, an essential
event for the whole blood IFN-γ ELISA assay for bTB [48].
However, the IFN-γ gene was not useful for separating
infected from noninfected cattle in the current study because
theexpressionlevelsforthatgenevariedconsiderablyamong
animals both within and between groups. Similarly, vari-
ability was observed in the amount of IFN-γ detected using
the whole blood IFN-γ ELISA assay on samples of blood
obtained from cattle in the current study (data not shown).
Furthermore, the levels of altered expression of mRNA did
not correlate with optical density readings from plasma in
the IFN-γ ELISA assay.
The gene expression data from qPCR assays were ana-
lyzed to identify gene targets that might diﬀerentiate ante-
mortem test-false positive cattle from the true bTB-infected
cattle. Diﬀerentiation of the DFP cattle from the bTB group
and the SFP groups of cattle was possible based on the
expressionlevelsof5and16genes,respectively(Figure 4(a)).
However, only one of the genes subjected to qPCR assay
could diﬀerentiate the bTB group of cattle from the SFP
group. The origin of the cattle in the SFP group suggested
a possible explanation for that ﬁnding. All of the cattle in the
SFP group were exposed to M. bovis infected cohorts; thus,
it was possible that some of the cattle in the SFP group had
been infected with M. bovis. Similarly, a few of the cattle in
the DFP group were exposed to M. bovis infected cohorts.
We could not reevaluate the SFP group; however, we could
reevaluate the DFP group by forming a new group of cattle
(DFP-non-ex) that consisted of cattle with no known expo-
sure to M. bovis. When the data from the qPCR were rean-
alyzed using the new groups of cattle, the list of genes that
had statistically signiﬁcant diﬀerential power to separate the
DFPnon-ex-groupfromthebTBgroupincreasedinnumber
f r o m5t o8( Figure 4(b)).
The process of postmortem examination is not perfect;
infections with M. bovis prior to lesion development may
not be detected. It is thought that up to 30% of cattle in an
infectedherdcanbecomeinfectedwithbTB[49].Cattlewith
an eﬀective innate immune response may clear an infection
with M. bovis. In that event, those cattle might test positive
by TST and/or IFN-γ ELISA assay but lack lesions at post-
mortem examination and be negative for M. bovis on bac-
terial culture [50]. Similarly, cattle in an early stage of infec-
tion with M. bovis may test positive by TST and/or IFN-γ
ELISA assay but lack lesions at postmortem examination
and be negative on cultures for M. bovis [51, 52]. Latent
infection is known to occur in humans infected with M.
tuberculosis, and it is believed that latent bTB infection can
occur in cattle [53–56]. It is likely that some latently infected
cattle would test positive by TST and/or IFN-γ ELISA assay
but lack lesions at postmortem examination and be negative
on cultures for M. bovis [53, 54]. Thus, failure to identify
genes with altered expression that can diﬀerentiate bTB-
infected cattle from antemortem test-false positive-bTB-
exposed cattle may have been due to use of “non-infected”
cattle that were, or had been, infected with bTB.
The current study examined altered expression of genes
in PBMC at 4 hours following stimulation with bPPD. The
gene expression proﬁles of the DFP-non-ex group of cattle
were clearly diﬀerent than those of the bTB group of cattle.
That ﬁnding provides support for the hypothesis that detec-
tion of altered expression of a few genes could be used to
diﬀerentiate bTB-infected cattle and antemortem test-false
positive cattle from bTB-free herds. Temporal studies that10 Veterinary Medicine International
used antigen stimulation of PBMC from cattle infected with
bTB have shown that there is a rapid and transient burst
of gene expression that occurs within hours of antigen
stimulation.Asecondburstofalteredgeneexpressionoccurs
at 12 to 24 hours after stimulation [16, 22, 23]. The current
study tried to capitalize on the early burst of altered gene
expression. We recently conducted a similar study analyzing
geneexpressionproﬁlesafterovernightstimulationofPBMC
with antigen. As expected, it was observed that many of the
genes that showed altered expression after 4 hours of antigen
stimulation in the current study did not show altered expres-
sion after overnight incubation with antigen. Instead a new
set of genes with altered expression were identiﬁed that may
be evaluated for use as molecular markers for segregation of
bTB-infected cattle from noninfected cattle. The results of
the current study indicate that monitoring altered expression
of genes with diﬀerential power has potential to separate
bTB-infected cattle from antemortem test-false positive
cattle in bTB-free herds. However, further studies are needed
to evaluate the gene expression proﬁles of the antemortem
test-false positive cattle from both low-risk herds for bTB
exposure and cattle from bTB-infected herds.
5. Conclusions
The results from diﬀerential gene expression analyses
reported here clearly showed that gene expression proﬁles
diﬀeredbetweentheDFP-non-exgroupofcattleandthebTB
group of cattle. However, diﬀerentiating the bTB-infected
cattle from the antemortem test-false positive cattle that
had been exposed to bTB infected cattle in the ﬁeld was
problematic. Therefore, further work is needed to gain a
better understanding of the distinct diﬀerences in gene
expression proﬁles of these cattle. The results from this study
are encouraging for use of altered gene expression proﬁles in
the development of ancillary tests for bTB that can improve
the diagnostic process and reduce the unnecessary destruc-
tion of antemortem test-false positive cattle from bTB-free
herds.
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